Hepatitis E vaccine recombinant (Changchun Institute of Biological Products)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis E vaccine recombinant (Changchun Institute of Biological Products)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis E
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesChangchun Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSoutheast UniversityChangchun Institute Of Biological Products Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis E

Other Information

ATC CodeN/A
Related LinksN/A